CanImmDB

Welcome to CanIMMDB

CanIMMDB is a manually curated resource which provides comprehensive information on immunomodulatory effects of anticancer drugs and antineoplastic agents. This database has compiled experimental verified information like antitumor and pro-tumor immunomodulation by anticancer drugs. This information of change in immune associated parameters has prognostic value and a thorough understanding of them can help create novel combinatorial regimens with enhanced clinical efficacy .The database's entries are connected to Pubchem, KEGG, Drugbank, and Pubmed. With several databases integrated into a single resource, users can browse vast information on a single platform.

Slide 1 Statistical Information 2 Statistical Information 1 Statistical Information 1

Immunomodulation by anticancer drugs/agents (figure 1)

Anticancer agents/drugs can alter immune associated parameters- cell types, phenotypes and function of the host immune system.The Mechanisms (figure 1) by which anticancer agents alter immune function include depleting immunosuppressive populations (both in circulation and tumor infiltrating) such as myeloid-derived suppressor cells (MDSCs) and Regulatory T cells. and downregulating PD-L2 mediated immunosuppression.These anticancer agents can trigger immunogenic cell death and antibody-dependent cellular cytotoxicity (ADCC). Anticancer agents induce various effector cell populations including tumor specific IL-17–producing γδ T cells , IFN-γ producing CD8 T cells, CD4+ T helper 17 (Th17), Natural killer cells, dendritic cells , macrophages and B cells. Anticancer agents suppress Protumor cytokines including IL-4, IL-10, and IL-13 and induce anti tumor immune response by releasing MCP-1, IFN-gamma, IL-17, Upregulating Class I and Class II MHC expression on tumor. In addition to these, many other mechanisms are cataloged in this database.